RxDoctor Payments DataLook up a doctor →

Sarah Bedell, MD

Obstetrics & Gynecology · Miami, FLNPI 1902149255

Payments from drug & device makers

$1,102,862in general payments, 2019–2025

Across 83 payments — averaging $13,287 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Eli Lilly$778K
  • Incyte Corporation$323K
  • AbbVie$420
  • Astellas Pharma US Inc$146
  • Sage Therapeutics, LLC$137
  • Mylan Pharmaceuticals Inc.$79
  • plus $296 from 11 others
$290,600in research payments, 2019–2025

Across 1 payment — averaging $290,600 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$291K

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,102,862 in reported general payments places this provider in the 95th percentile of 2,438 obstetrics & gynecology providers in Florida.

See all obstetrics & gynecology providers in Florida

Medicare billing

Part B allowed, 2024
$19,739
Medicare patients
89
Services billed
190

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other obstetrics & gynecology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →